Nettle Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 13-12-2024
- Paid Up Capital ₹ 0.10 M
as on 13-12-2024
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 387.27%
(FY 2020)
- Profit 150.39%
(FY 2020)
- Ebitda 45.56%
(FY 2020)
- Net Worth 15.93%
(FY 2020)
- Total Assets 24.62%
(FY 2020)
About Nettle Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mohammad Murtuja and Ravi Kumar serve as directors at the Company.
- CIN/LLPIN
U33110DL2012PTC243599
- Company No.
243599
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Oct 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nettle Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohammad Murtuja  | Director | 15-Sep-2018 | Current |
| Ravi Kumar | Director | 27-Apr-2018 | Current |
Financial Performance of Nettle Pharmaceuticals.
Nettle Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 387.27% increase. The company also saw a substantial improvement in profitability, with a 150.39% increase in profit. The company's net worth Soared by an impressive increase of 15.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nettle Pharmaceuticals?
In 2018, Nettle Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nettle Pharmaceuticals?
Unlock and access historical data on people associated with Nettle Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nettle Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nettle Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
